This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Event: 309

Key Event Title

A descriptive phrase which defines a discrete biological change that can be measured. More help

Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development

Short name

The KE short name should be a reasonable abbreviation of the KE title and is used in labelling this object throughout the AOP-Wiki. More help

Explore in a Third Party Tool

Biological Context

Structured terms, selected from a drop-down menu, are used to identify the level of biological organization for each KE. More help

Level of Biological Organization
Cellular

Cell term

The location/biological environment in which the event takes place.The biological context describes the location/biological environment in which the event takes place. For molecular/cellular events this would include the cellular context (if known), organ context, and species/life stage/sex for which the event is relevant. For tissue/organ events cellular context is not applicable. For individual/population events, the organ context is not applicable. Further information on Event Components and Biological Context may be viewed on the attached pdf. More help

Cell term
oocyte

Organ term

Key Event Components

The KE, as defined by a set structured ontology terms consisting of a biological process, object, and action with each term originating from one of 14 biological ontologies (Ives, et al., 2017; https://aopwiki.org/info_pages/2/info_linked_pages/7#List). Biological process describes dynamics of the underlying biological system (e.g., receptor signalling).Biological process describes dynamics of the underlying biological system (e.g., receptor signaling). The biological object is the subject of the perturbation (e.g., a specific biological receptor that is activated or inhibited). Action represents the direction of perturbation of this system (generally increased or decreased; e.g., ‘decreased’ in the case of a receptor that is inhibited to indicate a decrease in the signaling by that receptor). Note that when editing Event Components, clicking an existing Event Component from the Suggestions menu will autopopulate these fields, along with their source ID and description. To clear any fields before submitting the event component, use the 'Clear process,' 'Clear object,' or 'Clear action' buttons. If a desired term does not exist, a new term request may be made via Term Requests. Event components may not be edited; to edit an event component, remove the existing event component and create a new one using the terms that you wish to add. Further information on Event Components and Biological Context may be viewed on the attached pdf. More help

Process	Object	Action
receptor-mediated endocytosis	vitellogenins	decreased
oocyte growth		decreased
oocyte development		decreased

Key Event Overview

AOPs Including This Key Event

All of the AOPs that are linked to this KE will automatically be listed in this subsection. This table can be particularly useful for derivation of AOP networks including the KE.Clicking on the name of the AOP will bring you to the individual page for that AOP. More help

AOP Name	Role of event in AOP	Point of Contact	Author Status	OECD Status
Aromatase inhibition leading to reproductive dysfunction	KeyEvent	Dan Villeneuve (send email)	Open for citation & comment	WPHA/WNT Endorsed
Androgen receptor agonism leading to reproductive dysfunction	KeyEvent	Dan Villeneuve (send email)	Open for citation & comment	WPHA/WNT Endorsed
Estrogen receptor antagonism leading to reproductive dysfunction	KeyEvent	Dan Villeneuve (send email)	Open for citation & comment	Under Review
Prolyl hydroxylase inhibition	KeyEvent	Dalma Martinovic-Weigelt (send email)	Under Development: Contributions and Comments Welcome
Unknown MIE leading to reprodl	KeyEvent	Dalma Martinovic-Weigelt (send email)	Under Development: Contributions and Comments Welcome
AHR mediated epigenetic reproductive failure	KeyEvent	Jon Doering (send email)	Under development: Not open for comment. Do not cite
Androgen receptor agonism leading to reproduction dysfunction	KeyEvent	Hongling Liu (send email)	Under development: Not open for comment. Do not cite
ROS in Fish Ovary Impairs Reproduction	KeyEvent	Kevin Brix (send email)	Under development: Not open for comment. Do not cite
Aromatase inhibition leads to reproductive toxicity	KeyEvent	Hongling Liu (send email)	Under development: Not open for comment. Do not cite

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KE.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available in relation to this KE. More help

Term	Scientific Term	Evidence	Link
fathead minnow	Pimephales promelas	Moderate	NCBI
Oryzias latipes	Oryzias latipes	Moderate	NCBI

Life Stages

An indication of the the relevant life stage(s) for this KE. More help

Life stage	Evidence
Adult, reproductively mature	High

Sex Applicability

An indication of the the relevant sex for this KE. More help

Term	Evidence
Female	High

Key Event Description

A description of the biological state being observed or measured, the biological compartment in which it is measured, and its general role in the biology should be provided. More help

Vitellogenin from the blood is selectively taken up by competent oocytes via receptor-mediated endocytosis. Although vitellogenin receptors mediate the uptake, opening of intercellular channels through the follicular layers to the oocyte surface as the oocyte reaches a “critical” size is thought to be a key trigger in allowing vitellogenin uptake (Tyler and Sumpter 1996). Once critical size is achieved, concentrations in the plasma and temperature are thought to impose the primary limits on uptake (Tyler and Sumpter 1996). Uptake of vitellogenin into oocytes causes considerable oocyte growth during vitellogenesis, accounting for up to 95% of the final egg size in many fish (Tyler and Sumpter 1996). Given the central role of vitellogenesis in oocyte maturation, vitellogenin accumulation is a prominent feature used in histological staging of oocytes (e.g., (Leino et al. 2005; Wolf et al. 2004).

How It Is Measured or Detected

A description of the type(s) of measurements that can be employed to evaluate the KE and the relative level of scientific confidence in those measurements.These can range from citation of specific validated test guidelines, citation of specific methods published in the peer reviewed literature, or outlines of a general protocol or approach (e.g., a protein may be measured by ELISA). Do not provide detailed protocols. More help

Relative vitellogenin accumulation can be evaluated qualitatively using routine histological approaches (Leino et al. 2005; Wolf et al. 2004). Oocyte size can be evaluated qualitatively or quantitatively using routine histological and light microscopy and/or imaging approaches.

Domain of Applicability

A description of the scientific basis for the indicated domains of applicability and the WoE calls (if provided). More help

Oviparous vertebrates and invertebrates. Although hormonal regulation of vitellogenin synthesis and mechanisms of vitellogenin transport from the site of synthesis to the ovary vary between vertebrates and invertebrates (Wahli 1988), in both vertebrates and invertebrates, vitellogenin is incorporated into oocytes and cleaved to form yolk proteins.

References

List of the literature that was cited for this KE description. More help

Leino R, Jensen K, Ankley G. 2005. Gonadal histology and characteristic histopathology associated with endocrine disruption in the adult fathead minnow. Environmental Toxicology and Pharmacology 19: 85-98.
Tyler C, Sumpter J. 1996. Oocyte growth and development in teleosts. Reviews in Fish Biology and Fisheries 6: 287-318.
Wolf JC, Dietrich DR, Friederich U, Caunter J, Brown AR. 2004. Qualitative and quantitative histomorphologic assessment of fathead minnow Pimephales promelas gonads as an endpoint for evaluating endocrine-active compounds: a pilot methodology study. Toxicol Pathol 32(5): 600-612.